INGN

In the past six months, Inogen's stock experienced several notable events. In Q1 2026, Inogen reported revenue of $85.1 million, a 3.4% increase year-over-year, driven by international demand for portable oxygen concentrators. The company authorized a $30.0 million share repurchase program, repurchasing approximately 298,100 shares for nearly $1.9 million in Q1 2026. Inogen introduced Aurora CPAP masks in the U.S. and launched the Rove 6 portable oxygen concentrator in Brazil. As of April 22, 2026, Inogen's shares had gained 3.6% year-to-date, but as of July 17, 2025, a 13% pullback added to one-year losses for institutional owners.